Nuveen Asset Management LLC Grows Position in Invacare Co. (NYSE:IVC)

Nuveen Asset Management LLC lifted its holdings in shares of Invacare Co. (NYSE:IVC) by 203.8% in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 425,242 shares of the health services provider’s stock after purchasing an additional 285,279 shares during the quarter. Nuveen Asset Management LLC owned about 1.25% of Invacare worth $3,159,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Dynamic Technology Lab Private Ltd grew its holdings in shares of Invacare by 197.0% during the 4th quarter. Dynamic Technology Lab Private Ltd now owns 39,488 shares of the health services provider’s stock worth $356,000 after purchasing an additional 26,193 shares during the period. Geode Capital Management LLC grew its holdings in shares of Invacare by 18.4% during the 4th quarter. Geode Capital Management LLC now owns 495,713 shares of the health services provider’s stock worth $4,471,000 after purchasing an additional 77,180 shares during the period. Victory Capital Management Inc. grew its holdings in shares of Invacare by 11.9% during the 1st quarter. Victory Capital Management Inc. now owns 198,889 shares of the health services provider’s stock worth $1,478,000 after purchasing an additional 21,089 shares during the period. Goldman Sachs Group Inc. boosted its holdings in Invacare by 45.2% during the 4th quarter. Goldman Sachs Group Inc. now owns 315,397 shares of the health services provider’s stock valued at $2,845,000 after acquiring an additional 98,179 shares during the period. Finally, JPMorgan Chase & Co. boosted its holdings in Invacare by 301.3% during the 1st quarter. JPMorgan Chase & Co. now owns 516,344 shares of the health services provider’s stock valued at $3,837,000 after acquiring an additional 387,673 shares during the period.

Shares of IVC opened at $6.37 on Wednesday. The stock has a 50-day simple moving average of $6.60 and a 200-day simple moving average of $7.44. The company has a debt-to-equity ratio of 0.66, a quick ratio of 0.87 and a current ratio of 1.27. The stock has a market capitalization of $204.83 million, a PE ratio of -5.49 and a beta of 1.17. Invacare Co. has a 1 year low of $3.90 and a 1 year high of $11.63.

Invacare (NYSE:IVC) last announced its quarterly earnings data on Wednesday, May 6th. The health services provider reported ($0.21) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.22) by $0.01. The business had revenue of $218.44 million during the quarter, compared to analysts’ expectations of $218.00 million. Invacare had a negative return on equity of 10.17% and a negative net margin of 4.19%. Analysts predict that Invacare Co. will post -0.72 EPS for the current year.

IVC has been the subject of a number of research analyst reports. ValuEngine cut Invacare from a “buy” rating to a “hold” rating in a report on Monday, June 8th. Needham & Company LLC restated a “buy” rating and set a $17.00 target price on shares of Invacare in a report on Monday, June 1st. Stephens lowered their target price on Invacare from $17.00 to $11.00 and set an “overweight” rating for the company in a report on Monday, March 23rd. Finally, Zacks Investment Research cut Invacare from a “buy” rating to a “hold” rating in a report on Thursday, June 25th.

Invacare Company Profile

Invacare Corporation, together with its subsidiaries, designs, manufactures, distributes, and exports medical equipment for use in home health care, retail, and extended care markets worldwide. The company operates through Europe, North America/Home Medical Equipment, Institutional Products Group, and the Asia/Pacific segments.

Further Reading: What does an equal weight rating mean?

Institutional Ownership by Quarter for Invacare (NYSE:IVC)

Receive News & Ratings for Invacare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Invacare and related companies with MarketBeat.com's FREE daily email newsletter.